Latest filing published 25 Feb 2026 for Vera Therapeutics, Inc., €78k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
William D. Turner is a declared insider at 2 companies (senior executive); the most frequent names are Vera Therapeutics, Inc. and Sierra Oncology, Inc. We count 11 filings; the first trade dates from 26 January 2022 and the latest from 23 February 2026.
Every open-market trade on record is a sale: 1 sale worth €78k. Outside the open market, there are 2 share grants and 8 option exercises. Since January 2026: no purchases and 1 sale on the market.
The newest entry dates from 25 February 2026: an open-market sale of €78k, in Vera Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 of 11 declarations